Australia's largest stock trading and investment forum Australia's #1 stock forum

BOT

Click for more information

1.33%

38.0¢ botanix pharmaceuticals ltd

While still not from BOT so therefore take it with a grain of...

First 285 Last

Share
Profile

Follow
Mikey74

1,419 Posts.

286

20/06/24

23:20

Post #: 74415784
Share

Originally posted by dachopper: ↑

Understood, you are quoting a hypothetical net sales figure that was used by BOT as a hypothetical. They never said it would be that, and it's not net profit so you can't use it to calculate PE. My point was it cannot possibly be net profit as Tax alone is bigger than the margin.

BOT did say the price would command a higher value than competitors which are $690 a month. So we have a definante gross sales at least starting in the 700's.

When calculating PE, it's based on overall company profit and that needs to take into account all costs ( not just sales cost)

Having said that now, we are miles away from sales so SP could do anything in the meantime. It will respond to market demand, that should be good while we await Q4.

Expand

While still not from BOT so therefore take it with a grain of salt, this is from the E&P report - Page 41

In the U.S., seven major plans cover approximately 80% of lives, making these engagements crucial. While the progress of these
negotiations remains somewhat opaque and reliant on optimistic company guidance, it is assumed that Sofdra will be reimbursed at a
level commensurate with a unit list price of approximately $750 per prescription, with a gross-to-net adjustment of around 30%.

Last edited by Mikey74: 20/06/24

BOT Price at posting: 33.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Trimmed CPI figure provokes market jump of 1%, but inflation pressures remain a reality

MGU

New results confirm Buena Vista's iron grades potential

MRC

Mineral Commodities to shut down Tormin mineral sands project as oil spill contaminates beach

1CG

One Click Group jumps 4% after ending quarter with $2.4M in cash; $1M in revenue and 150K+ users on board

KOB

Koba, formerly a cobalt player, gears up to become newest explorer in the uranium state: South Australia

There are more pages in this discussion • 270 more messages in this thread...

First 285 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 38.0¢		Change 0.005(1.33%)		Mkt cap ! $687.8M

Open	High	Low	Value	Volume
37.5¢	38.0¢	36.0¢	$2.725M	7.415M

Buyers (Bids)

No.	Vol.	Price($)
3	70075	37.0¢

Sellers (Offers)

Price($)	Vol.	No.
38.0¢	422900	17

View Market Depth

No.	Vol.	Price($)
3	70075	0.370
5	550584	0.365
4	535584	0.360
15	548544	0.355
28	842340	0.350

Price($)	Vol.	No.
0.380	422900	17
0.385	278435	6
0.390	921220	6
0.395	624180	11
0.400	1389090	28

Last trade - 16.10pm 31/07/2024 (20 minute delay)

BOT (ASX) Chart